In a study appearing in Nature, members of the 1000 Genomes Project Consortium present an integrated haplotype map representing the genomic variation present in more than 1,000 individuals from 14 human populations.
Patrick Terry is leaving consulting firm Scientia Advisors, where he was head of the pricing, reimbursement, and market access practice.
Researchers at Cold Spring Harbor Laboratory are proposing to use high-throughput sequencing to map the human connectome. The team, led by Tony Zador, outlines its approach in PLOS Biology.
The Singapore National Research Foundation has awarded a $3 million fellowship to Slaven Garaj, formerly of the Nanopore Group at Harvard University, to develop a graphene nanopore sequencing device.
BG Medicine has appointed Charles Abdalian to be executive VP and chief financial officer. Mike Rogers will be departing the company after three-and-a-half years as CFO. Abdalian most recently was VP and CFO at Knome.
Caprotec Bioanalytics has appointed Jonathan Turner to be its CEO and managing director. Turner takes over the CEO spot from company founder Hubert Koester.
The Institute of Medicine of the National Academy of Sciences has elected 70 new members including Lynda Chin from the University of Texas M.D. Anderson Cancer Center, Stanford University's Stephen Quake, and Daniel Kastner at the National Human Genome Research Institute.
Philip Bourne has stepped down from his position as editor in chief of PLOS Computational Biology, a role he held for seven years. Ruth Nussinov, who has served as the journal's deputy editor in chief, will take over the spot.
The US Food and Drug Administration is beginning a pilot project to bring the Illumina MiSeq system into state and federal regional microbiology laboratories to test whether the technology makes sense for tracking food-borne pathogens and outbreaks.
The Genetics Society of America has awarded its 2013 GSA awards to five researchers, including the National Human Genome Research Institute's Elaine Ostrander and Malcolm Campbell from Davidson College.
Opko Health has received a $1 million grant from the Bill and Melinda Gates Foundation to develop a test to distinguish latent TB from active TB.
The UK government plans to provide £10 million over five years to fund the creation of a center to accelerate development of new synthetic biology technologies with an eye toward commercialization. The Biotechnology and Biological Sciences Research Council is seeking proposals from institutions interested in founding an Innovation and Knowledge Centre in Synthetic Biology to support and develop new businesses in the industry.
Canada has launched a C$41 million program to fund epigenetics research through collaborations between the Canadian Institute of Health Research, Genome Quebec and Genome BC, the government of Japan, and the Fonds de Recherche Sante in Quebec.
Qiagen is collaborating with Bayer HealthCare on developing companion diagnostics for Bayer drugs, with an initial focus on those that target solid tumors. The companion diagnostic tests will run on Qiagen's QIAsymphony automated instruments.
Greg Critchfield, former president of Myriad Genetics Laboratories, has been appointed as lead director of the board of Metamark Genetics. He has served on Metamark's board since September and is also CEO of Sera Prognostics.
Former graduate students at the University of California, Santa Cruz, have formed Five3 Genomics, a bioinformatics firm with a focus on cancer genomics.
Infectious disease diagnostics developer HiberGene Diagnostics has appointed Tony Hill as CEO. Hill joins HiberGene from Innogenetics, where he was global sales director.
The Centers for Medicare & Medicaid Services has decided to reimburse the new molecular pathology claims codes published by the American Medical Association in its payment channel dedicated to laboratory tests.
The Wellcome Trust and the UK's Medical Research Council are investing £12.8 million to create a database of induced pluripotent stem cells for use in a range of research projects. The Human Induced Pluripotent Stem Cell Initiative will be led by King's College London and the Wellcome Trust Sanger Institute.
23andMe has launched a new research platform, Research Portal Beta Program, that it will open up to a select group of outside investigators who then can bolster the company's findings with their own.
Theresa Brown is the new clinical laboratory director at Empire Genomics.